35Pharma is a Canada-based, private, clinical-stage biopharmaceutical company headquartered in Montreal, Quebec, with a research hub in Boston, Massachusetts. It designs and develops next-generation protein-based therapeutics — multi-specific Activin x GDF ligand traps engineered against the TGF-beta superfamily — for pulmonary hypertension, heart failure, cardiometabolic disease and obesity. Its lead program, HS235, is a precision-engineered activin signalling inhibitor that has completed Phase I healthy-volunteer studies and is entering proof-of-principle trials in PAH and PH-HFpEF; a second program, HS370, targets heart failure and obesity. 35Pharma publishes no developer program, API, or machine-readable API artifacts of any kind — it is a therapeutics developer, not a software or data provider. On 25 February 2026 the company announced an agreement to be acquired by GSK plc.
35Pharma is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Biopharmaceutical, and Drug Development.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/35pharma/"><img src="https://apis.io/badge/35pharma/card.svg" alt="35Pharma on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
13 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: 35pharma
name: 35Pharma
description: 35Pharma is a Canada-based, private, clinical-stage biopharmaceutical company headquartered in Montreal, Quebec,
with a research hub in Boston, Massachusetts. It designs and develops next-generation protein-based therapeutics — multi-specific
Activin x GDF ligand traps engineered against the TGF-beta superfamily — for pulmonary hypertension, heart failure, cardiometabolic
disease and obesity. Its lead program, HS235, is a precision-engineered activin signalling inhibitor that has completed
Phase I healthy-volunteer studies and is entering proof-of-principle trials in PAH and PH-HFpEF; a second program, HS370,
targets heart failure and obesity. 35Pharma publishes no developer program, API, or machine-readable API artifacts of any
kind — it is a therapeutics developer, not a software or data provider. On 25 February 2026 the company announced an agreement
to be acquired by GSK plc.
url: https://raw.githubusercontent.com/api-evangelist/35pharma/refs/heads/main/apis.yml
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source:
- security
generated: '2026-11-06'
method: derived
image: https://cdn.prod.website-files.com/679106f289641fbcc75092be/6920bf64870d13ff322aff0b_Open%20graph%20logo.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-parent-company: gsk
specificationVersion: '0.20'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Biopharmaceutical
- Drug Development
- Clinical Trials
- Life Sciences
- Protein Engineering
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://www.35pharma.com/
- type: PressReleases
url: https://www.35pharma.com/news
- type: Careers
url: https://www.35pharma.com/careers
- type: PrivacyPolicy
url: https://cdn.prod.website-files.com/679106f289641fbcc75092be/690117401d052d425a9a6c62_35Pharma_PrivacyPolicy_EN_FR.pdf
- type: ParentCompany
url: https://www.gsk.com
- type: DomainSecurity
url: security/35pharma-domain-security.yml
x-enrichment:
date: '2026-09-05'
status: minimal
artifacts_added: 2
pass: local-v3
x-coverage:
state: none
reason: not-a-software-company
detail: 35Pharma is a clinical-stage biopharmaceutical company developing Activin x GDF ligand-trap biologics (lead asset
HS235); its entire public site is seven marketing pages — technology, pipeline, about, careers, news, publications — with
no developer section, no API, and no machine-readable artifact on any probed path.
evidence:
- url: https://www.35pharma.com/sitemap.xml
status: 200
- url: https://www.35pharma.com/openapi.json
status: 404
- url: https://www.35pharma.com/llms.txt
status: 404
- url: https://www.35pharma.com/.well-known/agent-card.json
status: 404
- url: https://www.35pharma.com/apis.json
status: 404
checked: '2026-09-05'
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.